3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide

C31H33N3O5 — CID 93136451

IUPAC3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide
SMILESCOc1ccc(Oc2c(CN(C[C@H]3CCCO3)C(=O)c3cccc(OC)c3)c(-c3ccccc3)nn2C)cc1
InChIInChI=1S/C31H33N3O5/c1-33-31(39-25-16-14-24(36-2)15-17-25)28(29(32-33)22-9-5-4-6-10-22)21-34(20-27-13-8-18-38-27)30(35)23-11-7-12-26(19-23)37-3/h4-7,9-12,14-17,19,27H,8,13,18,20-21H2,1-3H3/t27-/m1/s1
InChIKeyUZCZZGOGYPXFKL-HHHXNRCGSA-N
MW527.62 g/mol
LogP5.72
Rot. Bonds10

About 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide

3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide (PubChem CID 93136451) has the molecular formula C31H33N3O5 and a molecular weight of 527.62 g/mol. Its IUPAC name is 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide.

Molecular Properties

Compound Name3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide
PubChem CID93136451
Molecular FormulaC31H33N3O5
Molecular Weight527.62 g/mol
Exact Mass527.24
IUPAC Name3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide
SMILESCOc1ccc(Oc2c(CN(C[C@H]3CCCO3)C(=O)c3cccc(OC)c3)c(-c3ccccc3)nn2C)cc1
InChIInChI=1S/C31H33N3O5/c1-33-31(39-25-16-14-24(36-2)15-17-25)28(29(32-33)22-9-5-4-6-10-22)21-34(20-27-13-8-18-38-27)30(35)23-11-7-12-26(19-23)37-3/h4-7,9-12,14-17,19,27H,8,13,18,20-21H2,1-3H3/t27-/m1/s1
InChIKeyUZCZZGOGYPXFKL-HHHXNRCGSA-N
XLogP5.72
TPSA75.05 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds10
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500527.62
LogP ≤ 55.72
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide?
The IUPAC name of 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide (CID 93136451) is 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide.
What is the SMILES notation for 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide?
The canonical SMILES for 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide is COc1ccc(Oc2c(CN(C[C@H]3CCCO3)C(=O)c3cccc(OC)c3)c(-c3ccccc3)nn2C)cc1.
What is the InChIKey of 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide?
The InChIKey is UZCZZGOGYPXFKL-HHHXNRCGSA-N. The full InChI is InChI=1S/C31H33N3O5/c1-33-31(39-25-16-14-24(36-2)15-17-25)28(29(32-33)22-9-5-4-6-10-22)21-34(20-27-13-8-18-38-27)30(35)23-11-7-12-26(19-23)37-3/h4-7,9-12,14-17,19,27H,8,13,18,20-21H2,1-3H3/t27-/m1/s1.
What are the key properties of 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide?
3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide has a molecular weight of 527.62 g/mol, XLogP of 5.72, 10 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methoxy-N-[[5-(4-methoxyphenoxy)-1-methyl-3-phenylpyrazol-4-yl]methyl]-N-[[(2R)-oxolan-2-yl]methyl]benzamide is sourced from PubChem (CID 93136451), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).